GSK

Behind the Science

Science EN ↓ Епізодів: 5

Welcome to Behind the Science with GSK and hosted by Dr. Kat Arney. In this new podcast, we unpack how today’s discoveries are shaping tomorrow’s health. Each episode brings you closer to the people and ideas having an impact on patients, communities and health systems around the world. Behind the Science is produced and funded by GSK.

Обов'язково відвідайте сайт подкасту та підтримайте його автора: behindthescience.podbean.com

Автор

GSK

Категорія

Science

Сайт подкасту

behindthescience.podbean.com

Останній епізод

9 жов 2026

Де слухати?

Подкасти в застосунку Replaio Radio Уже незабаром

Подкасти незабаром з'являться в застосунку. Встановіть уже зараз і першими побачте зовсім новий погляд на подкасти

Встановіть безкоштовно Android майже 10 млн завантажень · рейтинг 4,7+ iOS незабаром

Епізоди

Can science change the future of hepatitis B? 09.10.2026 25:19

Experts Joyeta Das & Jessica Hicks discuss a disease that is so quiet and unassuming, it's often called 'the silent disease’ – Hepatitis B. Developed and funded by GSK. Show note: In the third Behind the Science episode, Dr. Kat Arney speaks with Jessica Hicks, Senior Director of the World Hepatitis Alliance, and Joyeta Das, Senior Global Medical Director for hepatitis B at GSK, to take a c...

If 400m+ people live with COPD, why aren’t we talking about it? 21.07.2026 28:14

Experts Kaivan Khavandi and Dave Singh discuss diseases that affect a fundamental aspect of life – breathing. Developed and funded by GSK. Show note: In the second Behind the Science episode, Dr. Kat Arney speaks with Professor Dave Singh, a specialist in respiratory pharmacology at the University of Manchester, and Dr. Kaivan Khavandi, Senior Vice President and Global Head of Respiratory, Immuno...

Introducing: If 400m+ people live with COPD, why aren’t we talking about it? 13.07.2026 0:30

Kaivan Khavandi & Dave Singh discuss a disease that affects a fundamental aspect of life – breathing. Episode coming soon. Developed and funded by GSK.

Are we turning the tide on superbugs? 26.01.2026 32:48

Experts David Payne and Alison Holmes explore one of today’s biggest health challenges - antimicrobial resistance. Developed and funded by GSK. Show note: In the first Behind the Science episode, Dr. Kat Arney speaks with Professor Alison Holmes, Director of the Fleming Initiative, and David Payne, Head of Infectious Disease Research at GSK, to unpack the science, urgency and innovation behind...

Introducing: Are we turning the tide on superbugs? 20.01.2026 0:30

David Payne & Alison Holmes explore one of the biggest health challenges: antimicrobial resistance. Episode coming soon. Developed and funded by GSK